International Clinical Trial: The diagnosis for early ovarian cancer from the detection of AMH, D-dimer combined with serum CA125 and HE4

Geneva, April 20 -- International Clinical Trials Registry received information related to the study (ChiCTR2600122128) titled 'The diagnosis for early ovarian cancer from the detection of AMH, D-dimer combined with serum CA125 and HE4' on April 9.

Study Type: Observational study

Study Design: Case-Control study

Primary Sponsor: Yuebei People's Hospital

Condition: Benign ovarian tumo and ovarian cancer

Intervention: Ovarian benign tumor group:None Ovarian cancer group:None

Recruitment Status: Not Recruiting

Phase: N/A

Date of First Enrollment: 2026-04-09

Target Sample Size: Ovarian benign tumor group:60;Ovarian cancer group:60;Healthy control group:60;

Countries of Recruitment: China

To know more, visit https://www.chi...